AIM ImmunoTech Files to Sell 11.28M Shares of Common Stock for Holders

Seeking AlphaJul 11 18:00 ET

Advyzon Investment Management (AIM) Partners With FINIAT to Provide Turnkey Trading and Portfolio Management

New integration elevates portfolio management for financial services professionalsCHICAGO--(BUSINESS WIRE)--#CRM--Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under

BusinesswireJul 9 07:03 ET

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

OCALA, Fla., July 03, 2024 — AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today announced the next CEO Corner segment has been published on the Company's website. For the CEO C

AIM ImmunoTechJul 3 00:00 ET

AIM's Membership With ACIL Changes the Game in Lab Testing

LITTLETON, Colo., June 12, 2024 /PRNewswire/ -- Analytical Instrument Management (AIM) is excited to share the news of its inclusion into the esteemed American Council of Independent Laboratories (AC

PR NewswireJun 12 08:44 ET

AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference

Live video webcast on Monday, June 17th at 1:00 PM ETOCALA, Fla., June 10, 2024 — AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company"), today announced that Thomas K. Equels, MS JD, Ch

AIM ImmunoTechJun 10 00:00 ET

AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series

Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, June 5th at 12:00 PM ETOCALA, Fla., June 03, 2024 — AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or t

AIM ImmunoTechJun 3 00:00 ET